Join Richmond Pharmacology at this year s 10th Annual Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT), taking place on June 26-29 in Budapest, Hungary.The Congress will focus on key research and therapeutic areas, related challenges and latest achievements with the help of distinguished invited speakers, opinion leaders, experts and the upcoming future generation of clinical pharmacologists.We invite all attendees to join Richmond Pharmacology s Medical Director and Co-Founder Dr Ulrike Lorch at her presentation titled  frThe Use of Adaptive Study Design in Early Phase Clinical Research  scheduled for Day one, Session one at 10am.  For the full Scientific Programme of EACPT Congress please click here.In the last several years the interest in Adgaptive Study Design is evident from the growing amount of clinical research employing this model in the mid to later stages of medicines development.  Dr Lorch s presentation will describe where this design is of benefit to the conduct of First into Human and Early Phase Combination Studies and compare adaptive and conventional study design.  Little has been published on the practical application and merits of adaptive study design in Early Phase Clinical Research, so this presentation offers attendees a chance to learn more about the subject.If you would like to meet with Dr Ulrike Lorch, Richmond Pharmacology s CEO Dr Jorg Taubel.In the last several years the interest in Adaptive Study Design is evident from the growing amount of clinical research employing this model in the mid to later stages of medicines development.  Dr in advance to arrange a face-to-face meeting and discuss how Richmond Pharmacology can assist you with your current challenges.We hope to see you in Budapest to learn more about Richmond Pharmacology and enjoy one of Europe�s most lively cultural destinations.

Latest news

Futureproofing early phase clinical research for the next generation of investigators.

March 20, 2023
Richmond Pharmacology’s experienced Principal investigators and Co-investigators recently gave expert feedback on the ICH M11 (CeSHarP) protocol template.
Read more

Director of Operations, Keith Berelowitz, has been appointed as the Research Ethics Committee Chair for the Health Research Authority.

January 19, 2023
Keith Berelowitz will be responsible for ensuring that all ethical possibilities are explored in relation to new research.
Read more


13th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions

Sunday, June 4th to Tuesday June 6th 2023
Exchange research-based knowledge on drug-drug interactions (DDIs) among all interested stakeholders from pharmaceutical industry, regulatory authorities, academic and health care delivery backgrounds and perspectives.
View event